Neuramis is a brand of hyaluronic acid (HA)-based dermal fillers specifically engineered to address various signs of skin aging by restoring volume, hydrating tissue, and improving skin elasticity. It works by utilizing a unique, patented technology that creates a monophasic, highly cross-linked gel of non-animal stabilized hyaluronic acid. When injected into the skin by a medical professional, this gel integrates with the skin’s own tissues, providing immediate structural support and attracting and binding to water molecules for long-lasting hydration and a rejuvenated appearance.
The core ingredient, hyaluronic acid, is a glycosaminoglycan—a type of sugar molecule—that is naturally present in our skin, joints, and connective tissues. Its primary function is to retain water, keeping tissues well-lubricated and moist. However, natural HA production declines significantly with age, at an estimated rate of about 1-2% per year starting in our mid-20s. This degradation is a major contributor to the visible signs of aging, including wrinkles, loss of facial volume, and decreased skin suppleness. Neuramis fillers are designed to directly counteract this loss.
What sets the neuramis filler apart is its specific manufacturing process. The hyaluronic acid is produced via biofermentation, ensuring it is pure and free from animal proteins, which minimizes the risk of allergic reactions. The key innovation lies in the NASHA® (Non-Animal Stabilized Hyaluronic Acid) technology and its cross-linking agent, BDDE (1,4-Butanediol diglycidyl ether). The degree of cross-linking—the process that creates bonds between HA chains—is critically important. It determines the filler’s viscosity (thickness), elasticity (ability to return to its original shape after deformation), and longevity within the skin.
The following table compares the key physical properties of two popular Neuramis products, illustrating how their specific formulations are tailored for different treatment areas and depths.
| Product Name | Neuramis Deep | Neuramis Volume Lidocaine |
|---|---|---|
| HA Concentration | 22 mg/mL | 22 mg/mL |
| Indicated Depth | Deep dermis to subcutaneous layer | Subcutaneous to supraperiosteal layer |
| G’ (Elastic Modulus) | ~400 Pa | ~700 Pa |
| Primary Use | Moderate to severe wrinkles (e.g., nasolabial folds) | Volumizing (e.g., cheeks, chin, jawline) |
| Typical Longevity | 9-12 months | Up to 18 months |
As the table shows, a higher G’ value indicates a firmer, more robust gel that is better suited for lifting and supporting heavy facial structures. Neuramis Volume, with its higher elasticity, is designed to provide a scaffolding effect for significant volume restoration. In contrast, Neuramis Deep is softer, making it ideal for integrating smoothly into the dermis to fill lines and folds without feeling hard or palpable under the skin.
The mechanism of action for skin rejuvenation is a two-phase process. The first phase is the immediate structural correction. The physician injects the precise amount of gel needed to lift a wrinkle or restore lost volume. The gel’s physical presence pushes the skin upward from beneath, creating an instant smoothing and volumizing effect. This is why results are visible immediately after the procedure.
The second, and equally important, phase is the biochemical integration and hydration. Once in place, the cross-linked HA gel acts like a super-sponge. Each gram of hyaluronic acid can bind up to 1,000 times its own weight in water. This sustained hydration plumps the surrounding skin cells (fibroblasts and keratinocytes) from within, improving overall skin quality, texture, and radiance. Furthermore, the presence of this well-integrated gel may provide a subtle stimulus to the body’s own fibroblasts, encouraging them to produce more of their own collagen and elastin over time, a phenomenon sometimes referred to as “bio-revitalization.”
Clinical studies support these mechanisms. For instance, a 2015 study published in the Journal of Cosmetic Dermatology followed patients treated with Neuramis for nasolabial folds. Using the Wrinkle Severity Rating Scale (WSRS), investigators found that over 90% of patients maintained at least a one-point improvement on the scale for up to 9 months post-treatment. Patient satisfaction scores regarding natural look and feel were also consistently high, often above 85%.
Safety is a paramount consideration. The inclusion of lidocaine, a local anesthetic, in many Neuramis formulations significantly improves patient comfort during the injection process. Because the HA is non-animal derived and highly purified, the risk of immunogenic reactions is very low. The most common side effects are temporary and typical of any injectable procedure: mild swelling, redness, bruising, or tenderness at the injection site, which usually resolve within a few days to a week. As with all medical procedures, the skill and technique of the injector are critical factors in achieving a safe, natural, and effective outcome.
Beyond just wrinkle filling, the applications of Neuramis are diverse. Its range of products with different particle sizes and cohesivity allows for tailored treatments. For example, finer gels like Neuramis Pure are excellent for delicate areas like the under-eyes to correct tear troughs, or for fine perioral lines. The versatility of the line means a skilled practitioner can develop a comprehensive facial rejuvenation plan using different Neuramis products to address multiple concerns—from skin hydration with micro-droplet techniques (mesotherapy) to defining the jawline with a more structural product—in a single, cohesive treatment strategy.
